105
Participants
Start Date
August 19, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2027
RGT-61159
Oral MYB inhibitor
RECRUITING
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Next Oncology VA, Fairfax
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Ottawa Hospital Cancer Centre, Ottawa
RECRUITING
Princess Margaret Cancer Center, Toronto
Rgenta Therapeutics Inc
INDUSTRY